BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kawano H, Ito Y, Kanai F, Nakamura E, Tada N, Takai S, Horie S, Kobayashi T, Hino O. Aberrant differentiation of Tsc2-deficient teratomas associated with activation of the mTORC1-TFE3 pathway. Oncol Rep 2015;34:2251-8. [PMID: 26352760 DOI: 10.3892/or.2015.4254] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Ahmad S, Manon L, Bhat G, Machado J, Zalan A, Mata-Machado N, Garzon S, Yoshii A. A novel TSC1 variant associated with tuberous sclerosis and sacrococcygeal teratoma. Hum Genome Var 2020;7:39. [PMID: 33298910 DOI: 10.1038/s41439-020-00124-8] [Reference Citation Analysis]
2 Hino O, Kobayashi T. Mourning Dr. Alfred G. Knudson: the two-hit hypothesis, tumor suppressor genes, and the tuberous sclerosis complex. Cancer Sci. 2017;108:5-11. [PMID: 27862655 DOI: 10.1111/cas.13116] [Cited by in Crossref: 23] [Cited by in F6Publishing: 17] [Article Influence: 4.6] [Reference Citation Analysis]
3 Lichner Z, Mac-Way F, Yousef GM. Obstacles in Renal Regenerative Medicine: Metabolic and Epigenetic Parallels Between Cellular Reprogramming and Kidney Cancer Oncogenesis. Eur Urol Focus 2019;5:250-61. [PMID: 28847686 DOI: 10.1016/j.euf.2017.08.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
4 Asrani K, Murali S, Lam B, Na CH, Phatak P, Sood A, Kaur H, Khan Z, Noë M, Anchoori RK, Talbot CC Jr, Smith B, Skaro M, Lotan TL. mTORC1 feedback to AKT modulates lysosomal biogenesis through MiT/TFE regulation. J Clin Invest 2019;129:5584-99. [PMID: 31527310 DOI: 10.1172/JCI128287] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]